Reversion of KPC-114 to KPC-2 in ceftazidime-avibactam- resistant/meropenem-susceptible Klebsiella pneumoniae ST11 is related to low mutation rates.
Article in Microbiology Spectrum (August 2024)
The most recent citing publications are shown below. View all 13 publications that cite this research output on Dimensions.
In vitro mimicry of in vivo KPC mutations by ceftazidime-avibactam: phenotypes, mechanisms, genetic structure and kinetics of enzymatic hydrolysis
Article in Emerging Microbes & Infections (June 2024)
Loss and gain of ceftazidime-avibactam susceptibility in a non-carbapenemase-producing K1-ST23 hypervirulent Klebsiella pneumoniae
Article in Virulence (May 2024)